Table 3.

Primary and Secondary Outcomes Calculated Odds Ratio for Hematologic Malignancy (HM) Cohort vs General Population (GP) Cohort

	Odds Ratio(95% CI)	P value	Adjusted Odds Ratio (95% CI)	P value
Venous Thromboembolism (VTE)	2.34 (1.00 – 5.43)	0.049	2.14 (0.87 – 5.22)	.094
Cerebrovascular Accident	3.53 (1.16 – 10.73)	0.026	3.12 (0.96 – 10.15)	.058
Composite VTE/CVA	2.83 (1.42 – 5.63)	0.003	2.55 (1.23 – 5.27)	.011
Fatality Rate	4.32 (2.80 – 6.68)	<0.001	2.14 (1.32 – 3.46)	.002
Respiratory Support	3.37 (2.15 – 5.26)	<0.001	1.89 (1.17 – 3.05)	.009
ICU Admission	2.12 (1.36 – 3.29)	0.001	1.52 (0.95 – 2.43)	.079
ICU Duration (days, median [IQR])	1.34 (0.93 – 1.93)	0.113	1.53 (1.04 – 2.25)	.029
Ventilator Duration (days, median [IQR])	1.20 (0.75 – 1.91)	0.440	1.28 (0.78 – 2.08)	.317

Age adjusted odds ratios for HM cohort vs GP cohort.

Abbreviations: IQR = interquartile range.